The neurotoxic effects of activated microglia in neurodegenerative diseases are well established. We recently provided evidence that chromogranin A (CGA), a multifunctional protein localized in dystrophic neurites and in senile plaques, induces an activated phenotype and secretion of neurotoxins by rat microglia in culture. In the present study, we focused on the mechanisms underlying neuronal degeneration triggered by CGA-activated microglia. We found that neuronal death exhibits apoptotic features, characterized by the externalization of phosphatidylserine and the fragmentation of DNA. Microglial neurotoxins markedly stimulate the phosphorylation and activity of neuronal p38 mitogen-activated protein kinase (MAP kinase), and provoke the release of mitochondrial cytochrome c which precedes apoptosis. Inhibition of p38 kinase with SB 203580 partially protects neurons from death induced by CGA-activated microglia. Furthermore, neurons are also protected by Fas-Fc, which antagonizes the interactions between the death receptor Fas and its ligand FasL and by cell permeable peptides that inhibit caspases-8 and -3. Thus, CGA triggers the release of microglial neurotoxins that mobilize several death-signalling pathways in neurons. Our results further support the idea that CGA, which is upregulated in many neuropathologies, represents a potent endogeneous inflammatory factor possibly responsible for neuronal degeneration.
INTRODUCTION
Destruction of neurons by apoptosis and necrosis is the underlying mechanism in a variety of neurodegenerative diseases, and thus represents an area of intense interest (1, 2) . Activated microglial cells are capable of releasing cytotoxic agents, including cytokines, complement proteins, proteolytic enzymes, nitric oxide and reactive oxygen intermediates, and NMDA-like toxins (3) (4) (5) (6) (7) . Therefore, activation of microglia is considered to contribute to neuronal injury and has important pathogenic implications in neurodegenerative diseases such as Alzheimer's disease, Parkinson disease, or immunodeficiency virus-associated dementia (4, 6, 8, 11) . Despite their clinical importance, the brain-derived factors which control microglial activation and the precise intracellular mechanisms involved in microglial cytotoxicity remain elusive. The main constituent of amyloid plaques, β-amyloid protein, is believed to play a causal role in the pathogenesis of Alzheimer's disease and other neuropathological disorders (9) (10) (11) . Studies with synthetic peptides have shown that β-amyloid protein is directly toxic to cultured neurons (12, 13) , and also induces the production of proinflammatory cytokines in microglia (8) (9) (10) (11) . However,
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MATERIALS AND METHODS
Purification of bovine chromogranin A (CGA)
CGA was purified from bovine adrenal medullary chromaffin granules as described by Simon et al. (30) with an additional purification step on a column of Ultraspherogel Sec 2000 (7.5 x 30 mm, Beckman). Stock solutions usually containing 50 µM CGA were aliquoted and stored at -20°C. The final CGA preparation was composed of the native 70 kDa CGA (60 % of the total proteins) and smaller processed components (60 to 43 kDa) together representing 40 % of the total protein as estimated from scanned monodimensional electrophoretic profiles.
Immunoblotting indicated that all protein bands were immunoreactive with specific anti-native CGA antibodies (31) and anti-CGA [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] antibodies (30, 31) . Sequence analysis (by automatic Edman degradation on an Applied Biosystems 473A microsequencer) demonstrated that the final CGA preparation contained only CGA-derived sequences with 80 % of the sequenced material containing the N-terminal sequence of CGA (L-P-V-N-S-). The activity of the CGA preparations was systematically controlled by measuring the production of NO in microglial cell cultures as described previously (26, 27) .
The content of endotoxin in the CGA preparations was determined at the Institut d'Hygiène et de Médecine Préventive (Strasbourg, France) with the chromogenic Limulus amoebocyte lysate test (Coamatic Endotoxin Chromogenix, Biogenic, Maurin, France). At 10 nM, the CGA preparations contained less endotoxin than the culture medium alone, which itself is unable to trigger the NO production in microglial cells. CGA was usually dissolved in serumfree defined medium and applied to cultures by changing the medium at the indicated concentrations.
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Neuronal cultures
Neuronal cell cultures were established after mechanical dispersion of cerebral cortices from Wistar foetal (day 14 of gestation) rat brain as previously described (27) . Briefly, cerebral cortices cleaned from meninges were forced through a nylon sieve (pore size 48 µm) in nutrient medium consisting of Dulbecco's modified Eagle medium (DMEM) supplemented with 10% foetal calf serum. The cell suspension was centrifuged and cell viability determined with trypan blue. Viable cells were plated at a density of 2.5 x 10 5 cells per well in 24 multiwell Falcon plates coated with poly-L-ornithine in DMEM supplemented with 10% foetal calf serum. For immunocytochemistry, each well contained a 12 mm glass coverslip. Cells were subsequently incubated for 1 hour at 37°C in a 5% CO 2 humidified atmosphere. The serum-containing medium was then replaced by serum-free defined medium consisting of DMEM supplemented with transferrin (100 µg/ml), insulin (5 µg/ml), albumin (100 µg/ml), progesterone (6 ng/ml) and sodium selenite (5.2 ng/ml).
Microglial cultures
Microglial cells were isolated from high-density glial cell cultures as previously described (26) . Briefly, cells dissociated from cerebral hemispheres of neonatal rat brain (Wistar strain) were plated at a density of 5 x 10 4 cells/cm 2 in culture medium consisting of DMEM supplemented with 10% foetal calf serum. Culture medium was changed after 5 days and then twice a week. After 2 weeks, cultures contained glial cells including amoeboid microglia mostly localized on the top of the cellular layer. The loosely adherent microglial cells were recovered by shaking. After centrifugation (100 g/5 min), cell viability was determined by trypan blue 7 exclusion, and viable cells were then plated at a final density of 2.5 x 10 5 cells per well on 24 multiwell Falcon plates in DMEM supplemented with 10% foetal calf serum. Non-adherent cells were removed 30 min after plating by changing the medium for serum-free defined medium.
Amoeboid microglia isolated from neonatal rat brain cultures consist of flat, round or spindleshaped, highly adherent cells. They respond to bacterial endotoxin (32) and express Fc (33) and CR3 complement receptors (26) .
Conditioned medium was prepared by incubating microglial cell cultures for 24 hours in serum-free defined medium with or without 10 nM CGA. Medium was subsequently collected and cleared by centrifugation (1000 g/20 min). When necessary, the medium was stored at -20°C and used either non-diluted or diluted to 80% with serum-free defined medium. In all experiments, conditioned medium from CGA-untreated and CGA-treated microglia were collected simultaneously and used in parallel.
Neuron/Microglial co-cultures
Co-cultures of neurons and microglial cells were prepared by plating a suspension of isolated microglia (2.5 x 10 5 cells) on neurons maintained 4 days in culture. Cells were incubated for 30 min in DMEM containing 10% foetal calf serum. Serum-free defined medium with or without additives was then added and co-cultures were grown for at least 6 days.
Treatment of cultures
Neurons were grown for 4 days before being incubated with conditioned media from CGA-untreated or CGA-treated microglia for the indicated period of time. The emission signals were filtered with a 515-565 nm filter (FITC) or with a long pass 595 nm filter (TRITC). The images were recorded using identical laser power, wavelength and PM tube voltage. They were recorded digitally in a 768 x 556 pixel format and saved on a magneto optical disk.
Preparation of cell extracts and immunoblotting
Cell cultures were washed with PBS and lyzed in ice-cold lysis buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1 mM EDTA, 1 mg/ml pepstatin, 1 mM leupeptin, 0.2 mM phenylmethylsulfonyl fluoride, 5 mM sodium pyrophosphate, and 100 mM sodium fluoride) containing, 2% (v/v) Triton X-100 and 1 µg/ml DNAse I. Lysates were cleared by centrifugation (10 000 g for 10 min) and both, supernatants (Triton-X100-soluble cytosolic fractions) and pellets, (Triton X-100-insoluble cytoskeletal fractions) were resuspended in electrophoresis sample buffer, heated at 100°C for 10 min and stored in aliquots at -20°C before processing.
Cell extracts were resolved on 10% polyacrylamide-SDS gels and electroblotted onto nitrocellulose membranes (Sartorius, Goettingen, Germany). Blots were processed using the "Western-Light Plus" chemiluminescent detection system (Tropix, Bedford, MA) according to manufacturers instructions. The following antibodies to MAP kinases were used: anti-p38 MAP kinase, anti-phospho-specific p38 MAP kinase (Thr180/Tyr182), anti-c-Jun, anti-phosphospecific c-Jun (Ser63) II, (New England Biolabs, Beverley, MA), anti-p46 JNK1 (C-17) (Santa Cruz, CA) and anti-active JNK pAb (Promega, Madison WI). Immunoreactive bands were visualized after exposure to Kodak BioMax Light-1 film (Eastman Kodak, Rochester, NY). In some cases, blots were stripped in buffer containing 200 mM glycine, 0.1% SDS, 1.0% Tween-
Immunoprecipitation and assay of MAP kinases activities
Cell lysates (400 µg protein) were incubated on a shaking platform overnight at 4°C with 5 µl of protein G-Sepharose conjugated with 1 µg of either anti-p38 MAP kinase or anti-p46 JNK1 antibodies (StressGen Biotechnologie Corp, Victoria, Canada). The immunoprecipitates were washed twice with buffer containing 20 mM HEPES, 10% glycerol, 0.1% Triton X-100 and 500 mM NaCl, followed by two washes with the same buffer containing 150 mM NaCl. Kinase activity was assayed by incubating the resuspended pellet at 30°C, in the presence of 10 µCi {γ- 32 P}ATP and the appropriate substrate: myelin basic protein (3 µg) for p38 MAP kinase and GST-c-jun (1µg) for JNK1. After 20 min, the reaction was stopped by the addition of electrophoresis sample buffer and heating at 100°C for 5 min. The proteins were resolved on 10% polyacrylamide-SDS gels and the gels were dried and exposed to Phosphoimager screens (BioMax Light-1, Kodak).
Presentation of data
Experiments were performed on at least six different cell cultures. In the figures, data are representative of a typical experiment and are given as the mean of at least three determinations (± S.E.). The comparison between data obtained under different experimental conditions was analyzed by Student's t test. Differences were considered to be statistically significant when P < 0.01. 
RESULTS
Neuronal death in neuron/microglial co-cultures exposed to chromogranin A exhibits apoptotic features
We previously reported that exposure of neuron/microglial co-cultures to either bovine or recombinant human chromogranin A (CGA) induces a marked reduction in neuronal-specific [ 3 H]-GABA uptake and leads to neuronal degeneration (27) . To further characterize neuronal death induced by CGA-activated microglia, we examined the binding of annexin V and the fragmentation of nuclear DNA in neuron/microglial co-cultures treated with 10 nM CGA.
Binding of annexin V to the cell surface reveals the translocation of phosphatidylserine from the inner side of the plasma membrane to the outer layer. When used in conjunction with propidium iodide exclusion to establish membrane integrity, it indicates cells undergoing apoptosis (34, 35) .
In addition, we used the TUNEL technique to label DNA fragments at the 3'-OH DNA, and thus identify nuclear DNA which is cleaved by endonucleases (35) . Fig. 1 shows representative confocal images of neurons in co-culture with microglia for 3 days, incubated with or without 10 nM CGA. In untreated co-cultures, (Fig. 1A) annexin V (conjugated with fluorescein) did not bind to neurons, identified with anti-MAP2 antibody. In contrast, most neuronal bodies and processes in CGA-treated co-cultures were simultaneously stained for annexin V and MAP2 (Fig.   1B) . In both untreated and CGA-treated co-cultures, nuclei were generally not labelled with propidium iodide (PI) when living cells were exposed to PI before fixation, indicating that the plasma membrane is impermeable to the dye. The percentages of PI-positive, MAP2-positive neurons in resting and CGA-stimulated co-cultures were 5.8 ± 1.6 and 9.5 ± 1.9 (mean ± S.E.; n = 3), respectively. Using the TUNEL technique, labelling of nuclei was observed in only a few 14 MAP2-positive neurons in untreated co-cultures (Fig. 1C) . However, almost all nuclei of MAP2-positive neurons were stained in co-cultures exposed to CGA (Fig. 1D) . In addition, CGA-treated co-cultures contained a substantial proportion of TUNEL-positive, MAP2-negative cells, probably corresponding to microglia. Taken together, these results suggest that CGA induces an apoptotic cascade leading to neuronal death in neuron/microglial co-cultures.
Chromogranin A-activated microglia secrete diffusible factors that induce neuronal apoptosis
To further analyze the neurotoxic effect of microglia activated by CGA, we performed experiments on neurons maintained in pure culture. We previously reported that the toxic factors secreted by CGA-activated microglia are released into the culture medium, and as such can be collected (27) . Thus, cortical neurons were exposed to cell-free conditioned medium (CM) collected from either resting microglia or microglia treated for 24 h with 10 nM CGA, and the rate of apoptosis and necrosis was determined. In the early stages of apoptosis, the plasma membrane remains intact and impermeable to inert dyes such as trypan blue (36) . In contrast, necrosis is accompanied by a rapid loss of membrane integrity and the cell membrane becomes permeable. As shown in Fig. 2 , the proportion of necrotic neurons (stained with trypan blue) in CM from resting microglia does not exceed 10% of the total cell population. Furthermore, the percentage of apoptotic neurons revealed with the nuclear stain Hoechst 33342 remained lower than 15% over the whole experimental period. In contrast, in CM from CGA-treated microglia, 
Effect of neurotoxic factors secreted by chromogranin A-treated microglia on MAP kinase phosphorylation and activity in neurons
To investigate whether the neurotoxic factors secreted by CGA-treated microglia stimulate MAP kinases in neurons, we examined the presence and activation of c-Jun N-terminal kinase (JNK) and p38 MAP kinase, using antibodies which recognize the all forms, or the phosphorylated forms of the kinases. Fig. 3A shows that cultured cortical neurons express high levels of both JNK and p38 kinase. Both kinases were essentially present in the cytosol although a substantial fraction was also associated with cytoskeletal proteins. The relative distribution of total and phosphorylated forms of JNK was not significantly affected by the CM from resting or CGA-stimulated microglia. As expected, neurons also expressed c-Jun and its phosphorylated form (results not shown). In contrast, phosphorylated p38 kinase was not detected in neurons exposed to CM from resting microglia. However, exposure to CM from CGA-treated microglia triggered the rapid appearance of the phosphorylated form of p38 kinase, particularly in the cytosolic fraction (Fig. 3A) .
To determine the time course of MAP kinase activation in response to CM from CGAtreated microglia, we measured kinase activities using appropriate substrates in immunoprecipitates obtained with specific antibodies. (Fig. 3B) .
To probe the involvement of p38 MAP kinase in the neurotoxic effects induced by CGAstimulated microglia, we examined the ability of SB 203580 to prevent apoptosis in neurons. Since activation of p38 kinase has been related to altered calcium homeostasis and/or production of free radicals, which are considered to be potent inducers of mitochondrial damage (2, 29), we examined whether the release of cytochrome c from mitochondria may account for the neuronal apoptosis induced by CGA-treated microglia.
Chromogranin A-stimulated microglia trigger the release of mitochondrial cytochrome c in neurons
The release of cytochrome c from mitochondria has recently been described as an early event that initiates apoptosis in neurons (2) and non-neuronal cells (29) . Once released, cytochrome c interacts with Apaf-1 (apoptotic protease-activating factor 1) and caspase-9 to proteolytically activate procaspase-3. This activation of caspases is responsible for the morphological and nuclear changes associated with apoptosis (10, (38) (39) (40) . To study whether microglial neurotoxins provoke the release of cytochrome c from mitochondria in neurons, we performed a double staining experiment with anti-cytochrome c antibody and the nuclear stain propidium iodide (Fig. 4) . In neurons exposed to CM from resting microglia (Fig. 4A, B) , antiby guest on http://www.jbc.org/ Downloaded from cytochrome c antibody revealed a punctuate staining in cell bodies and processes, consistent with the mitochondrial location of this enzyme (40) . This pattern of immunostaining was dramatically altered in neurons exposed to CM from CGA-stimulated microglia (Fig. 4C, D) . After a 36 h exposure, the punctuate immunostaining observed with the anti-cytochrome c antibody had disappeared in most of the neurons, indicating the release of cytochrome c from mitochondria and its dilution into the cytoplasm. Time course analysis showed that release of mitochondrial cytochrome c occured after 22 h of exposure to CGA-induced microglial toxins (Fig. 4E) . At 36 h, more than 70% of the neurons in CM from CGA-stimulated microglia had lost their punctuate anti-cytochrome c staining and exhibit diffuse fluorescence with propidium iodide, indicating that the nuclear chromatin is not yet condensed (Fig. 4C, D) . Thus, release of mitochondrial cytochrome c appears before development of nuclear apoptotic changes, suggesting that the leakage of cytochrome c from the mitochondria might account for the induction of neuronal apoptosis following treatment with medium from CGA-stimulated microglia.
Role of the Fas receptor in neuronal death induced by chromogranin A-stimulated microglia
The Fas/APO1/CD95 (Fas) transmembrane receptor including a cytoplasmic death domain (DD), and its ligand (FasL) have been recently described in neurons both in vitro (41, 42) and in the brain (43, 44) . Ligation of Fas with soluble or membrane bound FasL activates DD, which in turn forms docking sites for the cytoplasmic adapter protein FADD/MORT1. FADD binds then to pro-caspase-8, thereby triggering its autocatalytic activation and the proteolytic cascade leading to cell death (28, 43, 45) . FasL is also expressed on activated microglia and can be cleaved proteolytically from the cell surface by membrane-associated metalloproteinases (45) (46) (47) . Therefore, we examined the possible participation of Fas/FasL in mediating neuronal apoptosis in response to CGA-activated microglia.
We first asked whether CGA may affect the expression or distribution of FasL in microglial cells. As illustrated in Fig. 5 , immunostaining with polyclonal anti-FasL antibody revealed that FasL is already present in resting microglia (Fig. 5A ). Treatment with CGA had no pronounced effect on the overall immunoreactivity but clearly induced the appearance of a thin slightly irregular staining highlighting the plasma membrane (Fig. 5B) . Similar images were obtained with two distinct anti-FasL antibodies (results not shown). Thus, CGA seems to increase the association of FasL with the microglial cell surface.
To test the ability of Fas/FasL in triggering death of cultured cortical neurons, we used soluble FasL (sFasL), corresponding to a recombinant epitope-tagged form of the extracellular domain of human FasL. Incubation of Fas receptor-bearing cells with epitope-tagged sFasL and anti-tag antibodies, clusters sFasL and thereby Fas, leading to Fas activation (29) . Addition of sFasL and anti-tag antibodies to neurons cultured in CM from resting microglia triggered apoptosis in a dose-dependent manner (Fig. 5C ). The induction of neuronal apoptosis by sFasL was also found in neurons maintained in unconditioned medium (results not shown). Note however, that sFasL (50 ng/ml) and CM from CGA-stimulated microglia had no additive effect on the percentage of apoptotic neurons, suggesting that the factors released by CGA-activated microglia and sFasL induce apoptosis through a common mechanism.
To further probe the involvement of Fas signalling in the induction of neuronal death by neurotoxins secreted by CGA-stimulated microglia, we assessed the effect of Fas-Fc, which contains the extracellular domain of recombinant human Fas fused to the Fc domain of IgG1, and antagonizes the activation of Fas by FasL (28, 42) . Fas-Fc inhibited the death of neurons induced by a 48 h exposure to CM from CGA-stimulated microglia in a dose-dependent manner (Fig.   5D ). The maximal effect (approximately 75 % inhibition) was observed at 5 µg/ml Fas-Fc, which is close to the dose which prevents the death of cultured motoneurons (42) .
Signalling through Fas-receptors involves activations of caspase-8 followed by the downstream caspases, including caspase-3. Caspase-3 is also activated by caspase-9 in response to the release of mitochondrial cytochrome c (29, 48) . To test the involvement of these caspases in the death process induced by neurotoxins from CGA-stimulated microglia, we used the cell-permeable peptides IETD and DEVD which are reported to inhibit irreversibly and selectively caspase-8 and caspase-3, respectively (49) . Addition of these inhibitors to cultures of neurons, 1 h before incubation in CM from CGA-stimulated microglia, prevented neuronal death (Table 1) . After 48 h, IETD and DEVD reduced the apoptotic effect of CGA-activated microglia by 67 % and 80 %, respectively, consistent with the requirement for caspases-8 and -3 in CGA-mediated neuronal apoptosis.
DISCUSSION
Microglia are the resident macrophages of the central nervous system. They play an important role in determining neuronal survival and differentiation, and provide the nervous system with a line of defense against damage and infection by killing invading microorganisms and removing dying cells. Thus, the activation of microglia represents a beneficial physiological response in host defense. However, sustained microglial activity may contribute to the pathogenesis of neurodegeneration through the extensive release of various neurotoxic agents, such as proteases, proinflammatory cytokines, and reactive oxygen and nitrogen intermediates (3-7). The specific molecules that control microglia activity within the brain remain elusive. In numerous neurodegenerative diseases, CGA is up-regulated and colocalizes with reactive microglia. CGA is particularly prominent in senile plaques and constitutes one of the major protein along with β-amyloid protein in extracellular deposits associated with Alzheimer's disease (11, (15) (16) (17) . The presence of CGA in brain lesions led us to examine whether CGA could contribute to neuronal degeneration. We found that CGA can induce an activated phenotype in rodent microglial cells (26) and triggers the release of microglial factors that cause injury and degeneration of brain cortical neurons (27) .
In the present study, we examined the mechanisms by which neurotoxins released from microglia in response to CGA provoke neuronal death. Treatment of neuron/microglial co- The activation of p38 kinase has been related to altered calcium homeostasis and increase in free radicals and reactive oxygen species (2), which are considered as potent inducers of mitochondrial damage (2, 29) . Indeed, we found that exposure of neurons to CM from CGA- by guest on 
